Hypocholesterolaemic effect and anti-hypertensive properties of probiotics and prebiotics: A review

Journal of Functional Foods

Volumn 25, Issue , 2016, Pages 497-510

  Miremadi, Fatemeh ^a   Sherkat, Frank ^b   Stojanovska, Lily ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Anti hypertensive property; Hypercholesterolaemia; Hypertension; Hypocholesterolaemic effect; Synbiotic

Indexed keywords

EID: 84978518572     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.06.016     Document Type: Review

References (122)

1. Agata J., Masuda A., Takada M., Higashiura K., Murakami H., Miyazaki Y., Shimamoto K. High plasma immunoreactive leptin level in essential hypertension. American Journal of Hypertension 1997, 10:1171-1174.
2. Agerholm-Larsen L., Raben A., Haulrik N., Hansen A.S. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. European Journal of Clinical Nutrition 2000, 54:288-297.
3. Aihara K., Kajimoto O., Hirata H., Takahashi R., Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of American College of Nutrition 2005, 4:257-265.
4. Allender P.S., Cutler J.A., Follmann D., Cappucio F.P., Pryer J., Elliott P. Dietary calcium and blood pressure. Annals of Internal Medicine 1996, 124:825-831.
5. Andersson S.W., Skinner J., Ellega L., Welch A., Bingham S., Mulligan A., Andersson H., Khaw K. Intake of dietary plant sterols is inversely related to serum cholesterol concentration in men and women in the EPIC Norfolk population: A cross-sectional study. European Journal of Clinical Nutrition 2004, 58:1378-1385.
6. Belviso S., Giordano M., Dolci P., Zepp G. In vitro cholesterol-lowering activity of Lactobacillus plantarum and Lactobacillus paracasei strains isolated from the Italian Castelmagno PDO cheese. Dairy Science Technology 2009, 89:169-176.
7. Bertolami M.C., Faludi A.A., Batlouni M. Evaluation of the effects of a new fermented milk product Gaio on primary hypercholesterolemia. European Journal of Clinical Nutrition 1999, 53:97-101.
8. Bielecka M., Biedrzycka E., Majkowska A. Selection of probiotics and prebiotics for synbiotic and confirmation of their in vivo effectiveness. Food Research International 2002, 35:125-131.
9. Brighenti F., Casiraghi M.C., Canzi E., Ferrari A. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. European Journal of Clinical Nutrition 1999, 53:726-733.
10. Bull I.D., Lockheart M.J., Elhmmali M.M., Roberts D.J., Evershed R.P. The origin of faeces by means of biomarker detection. Environment International 2002, 27:647-654.
11. Burke V., Hodgson J.M., Beilin L.J., Giangiulioi N., Rogers P., Puddey I.B. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 2001, 38:821-826.
12. Cani P.D., Joly E., Horsmans Y., Delzenne N.M. Oligofructose promotes satiety in healthy human: A pilot study. European Journal of Clinical Nutrition 2006, 60:567-572.
13. Cani P.D., Neyrinck A.M., Maton N., Delzenne N.M. Oligofructose promotes satiety in rats fed a high-fat diet: Involvement of glucagon-like peptide-1. Obesity Research 2005, 13:1000-1007.
14. Causey J.L., Feirtag J.M., Gallaher D.D., Tungland B.C., Slavin J.L. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutrition Research 2000, 20:191-201.
15. Chazan B., Raz R., Shental Y., Sprecher H., Colodner R. Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis. The Israel Medical Association Journal 2008, 10:164-165.
16. Chen Z.Y., Ma K.Y., Liang Y., Peng C., Zuo Y. Role and classification of cholesterol-lowering functional foods. Journal of Functional Foods 2011, 3:61-69.
17. Chiang Y.R., Ismail W., Heintz D., Schaeffer C., Van Dorsselaer A., Fuchs G. Study of anoxic and oxic cholesterol metabolism by Sterolibacterium denitrificans. Journal of Bacteriology 2008, 190:905-914.
18. Choudhary S.P., Tran L.S. Phytosterols: Perspectives in human nutrition and clinical therapy. Current Medicinal Chemistry 2011, 18:4557-4567.
19. Chowdhury R., Warnakula S., Kunutsor S., Crowe F., Ward H.A., Johnson L., Franco O.H., Di Angelantonio E. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Annals of Internal Medicine 2014, 160:398-406.
20. Corzo G., Gilliland S.E. Bile salt hydrolase activity of three strains of Lactobacillus acidophilus. Journal of Dairy Science 1999, 82:472-480.
21. Dambekodi P.C., Gilliland S.E. Incorporation of cholesterol into the cellular membrane of Bifidobacterium longum. Journal of Dairy Science 1998, 81:1818-1824.
22. D'Aimmo M.R., Modesto M. Antibiotic resistance of lactic acid bacteria and bifidobacterium spp. isolated from dairy and pharmaceutical products. International Journal of Food Microbiology 2007, 115:35-42.
23. De Rodas B.Z., Gilliland S.E., Maxwell C.V. Hypocholesterolemic action of lactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced by diet. Journal of Dairy Science 1996, 79:2121-2128.
24. Delzenne N.M., Kok N. Effects of fructans-type prebiotics on lipid metabolism. American Journal of Clinical Nutrition 2001, 73:456S-458S.
25. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V., Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. Journal of Dairy Science 2011, 94:3288-3294.
26. Eliasson K., Ryttig K.R., Hylander B., Rossner S. A dietary fibre supplement in the treatment of mild hypertension: A randomized, double blind, placebo-controlled trial. Journal of Hypertension 1992, 1992:195-199.
27. Favier M.L., Moundras C., Demigné C., Rémésy C. Fermentable carbohydrates exert a more potent cholesterol-lowering effect than cholestyramine. Biochimica et Biophysica Acta 1995, 1258:115-121.
28. FAO/WHO Guidelines for the evaluation of probiotics in food 2002, Joint FAO/WHO Working Group, London/Ontario/Canada.
29. Fernandez M.L., Roy S., Vergara-Jimenez M. Resistant starch and cholestyramine have distinct effects on hepatic cholesterol metabolism in guinea pigs fed a hypercholesterolemic diet. Nutrition Research 2000, 20:837-849.
30. Ferrier K.E., Muhlmann M.H., Baguet J.-P., Cameron J.D., Jennings G.L., Dart A.M., Kingwell B.A. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. Journal of the American College of Cardiology 2002, 39:1020-1025.
31. FitzGerald R.J., Murray B.A., Walsh D.J. Hypotensive peptides from milk proteins. The Journal of Nutrition 2004, 134:980S-988S.
32. FSANZ Risk analysis in food regulation 2013, Canberra, Australia.
33. Fuller R. Probiotics in man and animals. Journal of Applied Microbiology 1989, 66:365-378.
34. Gallaher C.M., Munion J., Hesslink R., Wise J., Gallaher D.D. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. The Journal of Nutrition 2000, 130:2753-2759.
35. Gallaher D.D., Gallaher C.M., Mahrt G.J., Carr T.P., Hollingshead C.H., Hesslink R., Wise J.A. Glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. Journal of the American College of Nutrition 2002, 21:428-433.
36. Geol A.K., Dilbaghi N., Kamboj D.V., Singh L. Probiotics: Microbial Therapy for Health Modulation. Defence Science Journal 2006, 56:513-529.
37. Gibson G.R., Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. The Journal of Nutrition 2000, 130:391S-395S.
38. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 1995, 71:1401-1412.
39. Gilliland S.E., Nelson C.R., Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Applied and Enviromental Microbiology 1985, 49:377-381.
40. Greany K.A., Bonorden M.I.J., Hamilton-Reeves J.M., McMullen M.H., Wangen K.E., Phipps W.R., Kruzer M.S. Probiotic capsules do not lower plasma lipid in young women and men. European Journal of Clinical Nutrition 2008, 62:232-237.
41. Ha C.G., Cho J.K., Lee C.H., Chai Y.G., Ha Y.A., Shin S.H. Cholesterol lowering effect of Lactobacillus plantarum isolated from human feces. Journal of Microbiology and Biotechnology 2006, 16:1201-1209.
42. Hashmi A., Naeem N., Farooq Z.A., Masood S.B., Iqbal S.A., Naseer R.C. Effect of prebiotic galacto-oligosaccharides on serum lipid profile of hypercholesterolemics. Probiotics and Antimicrobial Proteins 2016, 8:19-30.
43. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T. A placebo controlled study of the effect of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition 1996, 64:767-771.
44. He J., Streiffer R.H., Whelton P.K. Effect of dietary fiber supplementation on blood pressure: A randomized, double-blind placebo-controlled trial. Journal of Hypertension 2004, 22:73-80.
45. Hsu C.K., Liao J.W., Chung Y.C., Hsieh C.P., Chan Y.C. Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. The Journal of Nutrition 2004, 134:1523-1528.
46. Hummel A.S., Hertel C., Holzapfel W.H., Franz C.M. Antibiotic resistances of starter and probiotic strains of lactic acid bacteria. Applied and Enviromental Microbiology 2007, 207:730-739.
47. Inagami T. The renin-angiotensin system. Essays in Biochemistry 1992, 28:147-164.
48. Jeun J., Kim S.-Y., Cho S.-Y., Jun H.-J., Park H., Seo J., Chung M., Lee S. Hypocholesterolemic effects of lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition 2010, 26:321-330.
49. Johnston C.I. Renin-angiotensin system: A dual tissue and hormonal system for cardiovascular control. Journal of Hypertension 1992, 10:13-26.
50. Jones M.L., Martoni C.J., Parent M., Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. The British Journal of Nutrition 2012, 107:1505-1513.
51. Keenan J.M., Pins J.J., Frazel C., Moran A., Turnquist L. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: A pilot trial. The Journal of Family Practice 2002, 51:369.
52. Kieling G., Schneider J., Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. European Journal of Clinical Nutrition 2002, 56:843-849.
53. Kimoto H., Ohmomo S., Okamoto T. Cholesterol removal from media by lactococci. Journal of Dairy Science 2002, 85:3182-3188.
54. Klaver F.A.M., Van der Meer R. The assumed assimilation of cholesterol by lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Applied and Environmental Microbiology 1993, 59:1120-1124.
55. Klinder A., Foster A., Caderni G., Femia A.P., Pool-Zobel B.L. Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis) and their synbiotic combination. Nutrition and Cancer 2004, 49:144-155.
56. Korhonen H. Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods 2009, 1:177-178.
57. Kumar M., Nagpal R., Kumar R., Hemalatha V., Kumar A., Chakraborty C., Singh B., Marotta F., Jain S., Yadav H. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Experimental Diabetes Research 2012, 2012:1-14.
58. Lairon D., Arnault N., Bertrais S., Planells R., Clero E., Hercberg S., Boutron-Ruault M.-C. Dietary fiber intake and risk factors for cardiovascular disease in French adults. American Journal of Clinical Nutrition 2005, 82:1185-1194.
59. Lecerf J.M., De Lorgeril M. Dietary cholesterol: From physiology to cardiovascular risk. The British Journal of Nutrition 2011, 106:6-14.
60. Lee Y.P., Mori T.A., Puddey I.B., Sipsas S., Ackland T.R., Beilin L.J., Hodgson J.M. Effects of lupin kernel flour-enriched bread on blood pressure: A controlled intervention study. American Journal of Clinical Nutrition 2009, 89:766-772.
61. Letexier D., Diraison F., Beylot M. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. American Journal of Clinical Nutrition 2003, 77:546-559.
62. Levrat-Verny M.A., Behr S., Mustad V., Rémésy C., Demigné C. Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption. The Journal of Nutrition 2000, 130:243-248.
63. Lewis S.J., Burmeister S. A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. European Journal of Clinical Nutrition 2005, 59:776-780.
64. Li G.H., Le G.W., Shi Y.H., Shrestha S. Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 2004, 24:469-486.
65. Lin M.Y., Chen T.W. Reduction of cholesterol by Lactobacillus acidophilus in culture broth. Journal of Food and Drug Analysis 2000, 8:97-102.
66. Liong M.T., Dunshea F.R., Shah N.P. Effects of a synbiotic containing lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high- and low-fat diets. The British Journal of Nutrition 2007, 98:736-744.
67. Liong M.T., Shah N.P. Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains. International Dairy Journal 2005, 15:391-398.
68. Liong M.T., Shah N.P. Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. Journal of Dairy Science 2006, 89:1390-1399.
69. Liong M.T., Shah N.P. Synbiotic effects of Lactobacillus acidophilus ATCC 4962, fructooligosaccharide, mannitol and inulin on serum lipid profiles, intestinal lactobacilli population and intestinal organic acids concentration in rats. Milchwissenschaft 2008, 63:196-199.
70. Lubbadeh W., Haddadin M.S.Y., Al-Tamimi M.A., Robinson R.K. Effect on the cholesterol content of fresh lamb of supplementing the feed of Awassi ewes and lambs with Lactobacillus acidophilus. Meat Science 1999, 52:381-385.
71. Luo J., Van Yperselle M., Rizkalla S.W., Rossi F., Bornet F.R., Slama G. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. The Journal of Nutrition 2000, 130:1572-1577.
72. Lye H.S., Rusul G., Liong M.T. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. Journal of Dairy Science 2010, 93:1383-1392.
73. Ma D., Feitosa M.F., Wilk J.B., Laramie J.M., Yu K., Leiendecker-Foster C., Borecki I.B. Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2009, 53:473-479.
74. Mann G.V., Spoerry A. Studies of a surfactant and cholesteremia in the Maasai. American Journal of Clinical Nutrition 1974, 27:464-469.
75. Meisel H. Overview on milk protein-derived peptides. International Dairy Journal 1998, 8:363-373.
76. Miremadi F., Ayyash M., Sherkat F., Stojanovska L. Cholesterol reduction mechanisms and fatty acid composition of cellular membranes of probiotic lactobacilli and bifidobacteria. Journal of Functional Foods 2014, 9:295-305.
77. Mizushima S., Ohshige K., Watanabe J., Kimura M., Kadowaki T., Nakamura Y., Tochikubo O., Ueshima H. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. American Journal of Hypertension 2004, 17:701-706.
78. Mortensen A., Poulsen M., Frandsen H. Effect of long-chained fructan raftilose ® hp on blood lipids and spontaneous atherosclerosis in low density receptor knockout mice. Nutrition Research 2002, 22:473-480.
79. Naruszewicz M., Johansson M.-L., Zapolska-Downar D., Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. American Journal of Clinical Nutrition 2002, 76:1249-1255.
80. Olano A., Chua J., Schroeder S., Minari A., Salvia M.L., Hall G. Weissella confusa (Basonym: Lactobacillus confusus) bacteremia: A case report. Journal of Clinical Microbiology 2001, 39:1604-1607.
81. Ong L., Shah N.P. Release and identification of angiotensin-converting enzyme-inhibitory peptides as influenced by ripening temperatures and probiotic adjuncts in cheddar cheeses. LWT - Food Science and Technology 2008, 41:1555-1566.
82. Ooi L., Liong M. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. International Journal of Molecule Science 2010, 11:2499-2522.
83. Ostlund R.E. Phytosterols and cholesterol metabolism. Current Opinion in Lipidology 2004, 15:37-41.
84. Pereira D.I.A., Gibson G.R. Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Applied and Environmental Microbiology 2002, 68:4689-4693.
85. Plat J., Mensink R.P. Plant stanol and sterol esters in the control of blood cholesterol levels: Mechanisms and safety aspects. American Journal of Cardiology 2005, 96:15-22.
86. Rahmouni K., Correia M., Haynes W.G., Mark A.L. Obesity-associated hypertension: New insights into mechanisms. Hypertension 2005, 45:9-14.
87. Rajkumar H., Mahmood N., Kumar M., Varikuti S.R. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: A randomized, controlled trial. Mediators Inflammation 2014, 2014:34-42.
88. Ramasamy K., Abdullah N., Wong M.C.V.L., Karuthan C., Ho Y.W. Bile salt deconjugation and cholesterol removal from media by Lactobacillus strains used as probiotics in chickens. Journal of the Science of Food and Agriculture 2010, 90:65-69.
89. Roberfroid M.B. Prebiotics and probiotics: Are they functional foods?. The American Journal of Clinical Nutrition 2000, 71:1682S-1687S.
90. Robertson M.D., Currie J.M., Morgan L.M., Jewell D.P., Frayn K.N. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 2003, 46:659-665.
91. Saad M.F., Rewer M., Selby J., Howard G., Jinagouda S., Fahmi S., Zaccaro D., Bergman R.N., Savage P.J., Haffner S.M. Insulin resistance and hypertension: The insulin resistance atherosclerosis study. Hypertension 2004, 43:1324-1331.
92. Sanders M., Guarner F., Guerrant R., Holt P., Quigley E., Sartor R., Sherman P., Mayer E. An update on the use and investigation of probiotics in health and disease. Gut 2013, 62:787-796.
93. Schley P.D., Field C.J. The immune-enhancing effects of dietary fiber and prebiotics. The British Journal of Nutrition 2002, 87:221-230.
94. Scholz-Ahrens K.E., Acil Y., Schrezenmeir J. Effect of oligofructose or dietary calcium on repeated calcium and phosphorus balance, bone mineralization and trabecular structure in ovariectomized rat. The British Journal of Nutrition 2002, 88:365-377.
95. Scholz-Ahrens K.E., Ade P., Marten B., Weber P., Timm W., Asil Y., Gluer C., Schrezenmeir J. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. The Journal of Nutrition 2007, 137:838-846.
96. Scholz-Ahrens K.E., Schaafsma G., van den Heuvel E.G., Schrezenmeir J. Effects of prebiotics on mineral metabolism. The American Journal of Clinical Nutrition 2001, 73:459S-464S.
97. Seppo L., Jauhiainen T., Poussa T., Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 2003, 77:326-330.
98. Shimizu N., Kamezaki F., Shigematsu S. Tracking of microinjected DNA in live cells reveals the intracellular behavior and elimination of extrachromosomal genetic material. Nucleic Acids Research 2005, 33:6296-6307.
99. Simons L.A., Amansec S.G., Conway P. Effect of lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutrition, Metabolism, and Cardiovascular Diseases 2006, 16:531-535.
100. Sindhu S.C., Khetarpaul N. Effect of feeding probiotic fermented indigenous food mixture on serum cholesterol levels in mice. Nutrition Research 2003, 23:1071-1080.
101. Songisepp E., Kullisaar T., Hutt P., Elias P., Brilene T., Zilmer M., Mikelsaar M. A new probiotic cheese with antioxidative and antimicrobial activity. Journal of Dairy Science 2004, 87:2017-2023.
102. St-Onge M., Farnworth E., Jones P.J. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. The American Journal of Clinical Nutrition 2000, 71:674-681.
103. Streppel M.T., Arends L.R., van 't Veer P., Grobbee D.E., Geleijnse J.M. Dietary fiber and blood pressure: A meta-analysis of randomized placebo-controlled trials. Archives of Internal Medicine Journal 2005, 165:150-156.
104. Tan K.P., Yang M., Ito S. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress. Molecular Pharmacology 2007, 72:1380-1390.
105. Tanaka H., Hashiba H., Kok J., Mierau I. Bile salt hydrolase of Bifidobacterium longum - biochemical and genetic characterization. Applied and Environmental Microbiology 2000, 66:2502-2512.
106. Ten Bruggencate S.J., Bovee-Oudenhoven I.M., Lettink-Wissink M.L., Katan M.B., Van Der Meer R. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: Protective role of calcium. Gut 2004, 53:530-535.
107. Ten Bruggencate S.J., Bovee-Oudenhoven I.M., Lettink-Wissink M.L., Van deer Meer R. Dietary fructooligosaccharides increase intestinal permeability in rats. The Journal of Nutrition 2005, 135:837-842.
108. Tok E., Aslim B. Cholesterol removal by some lactic acid bacteria that can be used as probiotic. Microbiology and Immunology 2010, 54:257-264.
109. Torpy J.M. Coronary heart disease risk factors. JAMA: The Journal of the American Medical Association 2009, 302:2388.
110. Tripathi M., Giri S. Probiotic functional foods: Survival of probiotics during processing and storage. Journal of Functional Foods 2014, 9:225-241.
111. Vulevic J., Drakoularakou A., Yaqoob P., Tzortzis G., Gibson G.R. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (BGOS) in healthy elderly volunteers. American Journal of Clinical Nutrition 2008, 88:1438-1446.
112. Walker D.K., Gilliland S.E. Relationship among bile tolerance, bile salt deconjugation, and assimilation of cholesterol by Lactobacillus acidophilus. Journal of Dairy Science 1993, 76:956-961.
113. Watson R., Preedy V. Bioactive foods in promoting foods: Pobiotics and prebiotics 2010, 73-90. Elsevier, UK. 1st ed.
114. WHO Cardiovascular diseases: Fact sheet N°317 2009, Geneva, Switzerland.
115. WHO Cardiovascular diseases (CVDs): Fact sheet N°317 2015.
116. Wolever T., Schrade K.B., Vogt A., Tsihlias E.B., McBurney M.I. Do colonic short chain fatty acids contribute to the long-term adaptation of blood lipids in subjects with type 2 diabetes consuming a high fiber diet?. The American Journal of Clinical Nutrition 2002, 75:1023-1030.
117. Wong A. Chemical and microbiological considerations of phytosterols and their relative efficacies in functional foods for the lowering of serum cholesterol levels in humans: A review. Journal of Functional Foods 2014, 6:60-72.
118. Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., Yanagisawa M. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:1045-1050.
119. Yekeen L.A., Sanusi R.A., Ketiku A.O. Prevalence of obesity and high level of cholesterol in hypertension: Analysis of data from the Univesrity College Hospital, Ibadan. African Journal of Biomedical Research 2003, 6:129-132.
120. Yeo S.K., Liong M.T. Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics. International Journal of Food Sciences and Nutrition 2010, 61:161-181.
121. Zhang D., Garuti R., Tang W.J., Cohen J., Hobbs H. Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13045-13050.
122. Zhang F., Hang X., Fan X., Li G., Yang H. Selection and optimization procedure of synbiotic for cholesterol removal. Anaerobe 2007, 13:185-192.